Ad Code: 23160

“To date, most research we have seen on psoriasis and atopic dermatitis (AD) has focused on the patient’s clinical experience, meaning that they are clinical studies with clinical measures made by physicians,” explains Aaron...

Patients with atopic dermatitis (AD) experienced considerably greater issues with HRQOL during, compared with before, the COVID-19 pandemic, according to a study published in Dermatitis. For the study, Kamilla Koszorú, MD, and...

In adults with atopic dermatitis (AD), dupilumab improves skin barrier function better than topical corticosteroids (TCS) or cyclosporine, both in nonlesioned skin and eczematous lesions, according to a study published in the...